Ropes & Gray Represents RTW Investments in Neurosterix’s $105 Million Series B Financing

In The News
November 16, 2026

Ropes & Gray represented RTW Investments as it led Neurosterix’s $105 million Series B financing. Neurosterix is a Boston- and Geneva-based clinical-stage biotechnology company focused on transforming neuropsychiatric care through selective allosteric modulation.

The Ropes & Gray team included venture capital and emerging companies partner Rajarshi Banerjee and associate Alyce Chen, tax partner Zhen Zhang, and venture capital and emerging companies associates Jordan Kiellach and Yahel Kaplan.